Based on the Antiviral Drugs market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Antiviral Drugs market covered in Chapter 5:
Gilead Sciences
AbbVie
Novartis
Merck
Bristol-Myers Squibb
GlaxoSmithKline
Roche
Johnson & Johnson
In Chapter 6, on the basis of types, the Antiviral Drugs market from 2015 to 2025 is primarily split into:
Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Immune System Modulators
In Chapter 7, on the basis of applications, the Antiviral Drugs market from 2015 to 2025 covers:
Hepatitis Therapeutics
HIV/AIDS Therapeutics
Herpes Therapeutics
Influenza Therapeutics
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content 1 Market Overview 1.1 Product Definition and Market Characteristics 1.2 Global Antiviral Drugs Market Size 1.3 Market Segmentation 1.4 Global Macroeconomic Analysis 1.5 SWOT Analysis 2. Market Dynamics 2.1 Market Drivers 2.2 Market Constraints and Challenges 2.3 Emerging Market Trends 2.4 Impact of COVID-192.4.1 Short-term Impact 2.4.2 Long-term Impact 3 Associated Industry Assessment 3.1 Supply Chain Analysis 3.2 Industry Active Participants3.2.1 Suppliers of Raw Materials 3.2.2 Key Distributors/Retailers 3.3 Alternative Analysis 3.4 The Impact of Covid-19 From the Perspective of Industry Chain 4 Market Competitive Landscape 4.1 Industry Leading Players 4.2 Industry News4.2.1 Key Product Launch News 4.2.2 M&A and Expansion Plans 5 Analysis of Leading Companies 5.1 Gilead Sciences5.1.1 Gilead Sciences Company Profile 5.1.2 Gilead Sciences Business Overview 5.1.3 Gilead Sciences Antiviral Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020) 5.1.4 Gilead Sciences Antiviral Drugs Products Introduction 5.2 AbbVie5.2.1 AbbVie Company Profile 5.2.2 AbbVie Business Overview 5.2.3 AbbVie Antiviral Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020) 5.2.4 AbbVie Antiviral Drugs Products Introduction 5.3 Novartis5.3.1 Novartis Company Profile 5.3.2 Novartis Business Overview 5.3.3 Novartis Antiviral Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020) 5.3.4 Novartis Antiviral Drugs Products Introduction 5.4 Merck5.4.1 Merck Company Profile 5.4.2 Merck Business Overview 5.4.3 Merck Antiviral Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020) 5.4.4 Merck Antiviral Drugs Products Introduction 5.5 Bristol-Myers Squibb5.5.1 Bristol-Myers Squibb Company Profile 5.5.2 Bristol-Myers Squibb Business Overview 5.5.3 Bristol-Myers Squibb Antiviral Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020) 5.5.4 Bristol-Myers Squibb Antiviral Drugs Products Introduction 5.6 GlaxoSmithKline5.6.1 GlaxoSmithKline Company Profile 5.6.2 GlaxoSmithKline Business Overview 5.6.3 GlaxoSmithKline Antiviral Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020) 5.6.4 GlaxoSmithKline Antiviral Drugs Products Introduction 5.7 Roche5.7.1 Roche Company Profile 5.7.2 Roche Business Overview 5.7.3 Roche Antiviral Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020) 5.7.4 Roche Antiviral Drugs Products Introduction 5.8 Johnson & Johnson5.8.1 Johnson & Johnson Company Profile 5.8.2 Johnson & Johnson Business Overview 5.8.3 Johnson & Johnson Antiviral Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020) 5.8.4 Johnson & Johnson Antiviral Drugs Products Introduction 6 Market Analysis and Forecast, By Product Types 6.1 Global Antiviral Drugs Sales, Revenue and Market Share by Types (2015-2020)6.1.1 Global Antiviral Drugs Sales and Market Share by Types (2015-2020) 6.1.2 Global Antiviral Drugs Revenue and Market Share by Types (2015-2020) 6.1.3 Global Antiviral Drugs Price by Types (2015-2020) 6.2 Global Antiviral Drugs Market Forecast by Types (2020-2025)6.2.1 Global Antiviral Drugs Market Forecast Sales and Market Share by Types (2020-2025) 6.2.2 Global Antiviral Drugs Market Forecast Revenue and Market Share by Types (2020-2025) 6.3 Global Antiviral Drugs Sales, Price and Growth Rate by Types (2015-2020)6.3.1 Global Antiviral Drugs Sales, Price and Growth Rate of Reverse Transcriptase Inhibitors 6.3.2 Global Antiviral Drugs Sales, Price and Growth Rate of Protease Inhibitors 6.3.3 Global Antiviral Drugs Sales, Price and Growth Rate of Fusion Inhibitors 6.3.4 Global Antiviral Drugs Sales, Price and Growth Rate of Immune System Modulators 6.4 Global Antiviral Drugs Market Revenue and Sales Forecast, by Types (2020-2025)6.4.1 Reverse Transcriptase Inhibitors Market Revenue and Sales Forecast (2020-2025) 6.4.2 Protease Inhibitors Market Revenue and Sales Forecast (2020-2025) 6.4.3 Fusion Inhibitors Market Revenue and Sales Forecast (2020-2025) 6.4.4 Immune System Modulators Market Revenue and Sales Forecast (2020-2025) 7 Market Analysis and Forecast, By Applications 7.1 Global Antiviral Drugs Sales, Revenue and Market Share by Applications (2015-2020)7.1.1 Global Antiviral Drugs Sales and Market Share by Applications (2015-2020) 7.1.2 Global Antiviral Drugs Revenue and Market Share by Applications (2015-2020) 7.2 Global Antiviral Drugs Market Forecast by Applications (2020-2025)7.2.1 Global Antiviral Drugs Market Forecast Sales and Market Share by Applications (2020-2025) 7.2.2 Global Antiviral Drugs Market Forecast Revenue and Market Share by Applications (2020-2025) 7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)7.3.1 Global Antiviral Drugs Revenue, Sales and Growth Rate of Hepatitis Therapeutics (2015-2020) 7.3.2 Global Antiviral Drugs Revenue, Sales and Growth Rate of HIV/AIDS Therapeutics (2015-2020) 7.3.3 Global Antiviral Drugs Revenue, Sales and Growth Rate of Herpes Therapeutics (2015-2020) 7.3.4 Global Antiviral Drugs Revenue, Sales and Growth Rate of Influenza Therapeutics (2015-2020) 7.4 Global Antiviral Drugs Market Revenue and Sales Forecast, by Applications (2020-2025)7.4.1 Hepatitis Therapeutics Market Revenue and Sales Forecast (2020-2025) 7.4.2 HIV/AIDS Therapeutics Market Revenue and Sales Forecast (2020-2025) 7.4.3 Herpes Therapeutics Market Revenue and Sales Forecast (2020-2025) 7.4.4 Influenza Therapeutics Market Revenue and Sales Forecast (2020-2025) 8 Market Analysis and Forecast, By Regions 8.1 Global Antiviral Drugs Sales by Regions (2015-2020) 8.2 Global Antiviral Drugs Market Revenue by Regions (2015-2020) 8.3 Global Antiviral Drugs Market Forecast by Regions (2020-2025) 9 North America Antiviral Drugs Market Analysis 9.1 Market Overview and Prospect Analysis 9.2 North America Antiviral Drugs Market Sales and Growth Rate (2015-2020) 9.3 North America Antiviral Drugs Market Revenue and Growth Rate (2015-2020) 9.4 North America Antiviral Drugs Market Forecast 9.5 The Influence of COVID-19 on North America Market 9.6 North America Antiviral Drugs Market Analysis by Country9.6.1 U.S. Antiviral Drugs Sales and Growth Rate 9.6.2 Canada Antiviral Drugs Sales and Growth Rate 9.6.3 Mexico Antiviral Drugs Sales and Growth Rate 10 Europe Antiviral Drugs Market Analysis 10.1 Market Overview and Prospect Analysis 10.2 Europe Antiviral Drugs Market Sales and Growth Rate (2015-2020) 10.3 Europe Antiviral Drugs Market Revenue and Growth Rate (2015-2020) 10.4 Europe Antiviral Drugs Market Forecast 10.5 The Influence of COVID-19 on Europe Market 10.6 Europe Antiviral Drugs Market Analysis by Country10.6.1 Germany Antiviral Drugs Sales and Growth Rate 10.6.2 United Kingdom Antiviral Drugs Sales and Growth Rate 10.6.3 France Antiviral Drugs Sales and Growth Rate 10.6.4 Italy Antiviral Drugs Sales and Growth Rate 10.6.5 Spain Antiviral Drugs Sales and Growth Rate 10.6.6 Russia Antiviral Drugs Sales and Growth Rate 11 Asia-Pacific Antiviral Drugs Market Analysis 11.1 Market Overview and Prospect Analysis 11.2 Asia-Pacific Antiviral Drugs Market Sales and Growth Rate (2015-2020) 11.3 Asia-Pacific Antiviral Drugs Market Revenue and Growth Rate (2015-2020) 11.4 Asia-Pacific Antiviral Drugs Market Forecast 11.5 The Influence of COVID-19 on Asia Pacific Market 11.6 Asia-Pacific Antiviral Drugs Market Analysis by Country11.6.1 China Antiviral Drugs Sales and Growth Rate 11.6.2 Japan Antiviral Drugs Sales and Growth Rate 11.6.3 South Korea Antiviral Drugs Sales and Growth Rate 11.6.4 Australia Antiviral Drugs Sales and Growth Rate 11.6.5 India Antiviral Drugs Sales and Growth Rate 12 South America Antiviral Drugs Market Analysis 12.1 Market Overview and Prospect Analysis 12.2 South America Antiviral Drugs Market Sales and Growth Rate (2015-2020) 12.3 South America Antiviral Drugs Market Revenue and Growth Rate (2015-2020) 12.4 South America Antiviral Drugs Market Forecast 12.5 The Influence of COVID-19 on South America Market 12.6 South America Antiviral Drugs Market Analysis by Country12.6.1 Brazil Antiviral Drugs Sales and Growth Rate 12.6.2 Argentina Antiviral Drugs Sales and Growth Rate 12.6.3 Columbia Antiviral Drugs Sales and Growth Rate 13 Middle East and Africa Antiviral Drugs Market Analysis 13.1 Market Overview and Prospect Analysis 13.2 Middle East and Africa Antiviral Drugs Market Sales and Growth Rate (2015-2020) 13.3 Middle East and Africa Antiviral Drugs Market Revenue and Growth Rate (2015-2020) 13.4 Middle East and Africa Antiviral Drugs Market Forecast 13.5 The Influence of COVID-19 on Middle East and Africa Market 13.6 Middle East and Africa Antiviral Drugs Market Analysis by Country13.6.1 UAE Antiviral Drugs Sales and Growth Rate 13.6.2 Egypt Antiviral Drugs Sales and Growth Rate 13.6.3 South Africa Antiviral Drugs Sales and Growth Rate 14 Conclusions and Recommendations 14.1 Key Market Findings and Prospects 14.2 Advice for Investors 15 Appendix 15.1 Methodology 15.2 Research Data Source List of Tables and Figures Figure Product Picture Figure Global Antiviral Drugs Market Size and Growth Rate 2015-2025 Table Antiviral Drugs Key Market Segments Figure Global Antiviral Drugs Market Revenue ($) Segment by Type from 2015-2020 Figure Global Antiviral Drugs Market Revenue ($) Segment by Applications from 2015-2020 Table SWOT Analysis Figure Global COVID-19 Status Figure Supply Chain Table Major Players Headquarters, and Service Area of Antiviral Drugs Table Major Players Revenue in 2019 Figure Major Players Revenue Share in 2019 Table Gilead Sciences Company Profile Table Gilead Sciences Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020) Figure Gilead Sciences Production and Growth Rate Figure Gilead Sciences Market Revenue ($) Market Share 2015-2020 Table AbbVie Company Profile Table AbbVie Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020) Figure AbbVie Production and Growth Rate Figure AbbVie Market Revenue ($) Market Share 2015-2020 Table Novartis Company Profile Table Novartis Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020) Figure Novartis Production and Growth Rate Figure Novartis Market Revenue ($) Market Share 2015-2020 Table Merck Company Profile Table Merck Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020) Figure Merck Production and Growth Rate Figure Merck Market Revenue ($) Market Share 2015-2020 Table Bristol-Myers Squibb Company Profile Table Bristol-Myers Squibb Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020) Figure Bristol-Myers Squibb Production and Growth Rate Figure Bristol-Myers Squibb Market Revenue ($) Market Share 2015-2020 Table GlaxoSmithKline Company Profile Table GlaxoSmithKline Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020) Figure GlaxoSmithKline Production and Growth Rate Figure GlaxoSmithKline Market Revenue ($) Market Share 2015-2020 Table Roche Company Profile Table Roche Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020) Figure Roche Production and Growth Rate Figure Roche Market Revenue ($) Market Share 2015-2020 Table Johnson & Johnson Company Profile Table Johnson & Johnson Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020) Figure Johnson & Johnson Production and Growth Rate Figure Johnson & Johnson Market Revenue ($) Market Share 2015-2020 Table Global Antiviral Drugs Sales by Types (2015-2020) Table Global Antiviral Drugs Sales Share by Types (2015-2020) Table Global Antiviral Drugs Revenue ($) by Types (2015-2020) Table Global Antiviral Drugs Revenue Share by Types (2015-2020) Table Global Antiviral Drugs Price ($) by Types (2015-2020) Table Global Antiviral Drugs Market Forecast Sales by Types (2020-2025) Table Global Antiviral Drugs Market Forecast Sales Share by Types (2020-2025) Table Global Antiviral Drugs Market Forecast Revenue ($) by Types (2020-2025) Table Global Antiviral Drugs Market Forecast Revenue Share by Types (2020-2025) Figure Global Reverse Transcriptase Inhibitors Sales and Growth Rate (2015-2020) Figure Global Reverse Transcriptase Inhibitors Price (2015-2020) Figure Global Protease Inhibitors Sales and Growth Rate (2015-2020) Figure Global Protease Inhibitors Price (2015-2020) Figure Global Fusion Inhibitors Sales and Growth Rate (2015-2020) Figure Global Fusion Inhibitors Price (2015-2020) Figure Global Immune System Modulators Sales and Growth Rate (2015-2020) Figure Global Immune System Modulators Price (2015-2020) Figure Global Antiviral Drugs Market Revenue ($) and Growth Rate Forecast of Reverse Transcriptase Inhibitors (2020-2025) Figure Global Antiviral Drugs Sales and Growth Rate Forecast of Reverse Transcriptase Inhibitors (2020-2025) Figure Global Antiviral Drugs Market Revenue ($) and Growth Rate Forecast of Protease Inhibitors (2020-2025) Figure Global Antiviral Drugs Sales and Growth Rate Forecast of Protease Inhibitors (2020-2025) Figure Global Antiviral Drugs Market Revenue ($) and Growth Rate Forecast of Fusion Inhibitors (2020-2025) Figure Global Antiviral Drugs Sales and Growth Rate Forecast of Fusion Inhibitors (2020-2025) Figure Global Antiviral Drugs Market Revenue ($) and Growth Rate Forecast of Immune System Modulators (2020-2025) Figure Global Antiviral Drugs Sales and Growth Rate Forecast of Immune System Modulators (2020-2025) Table Global Antiviral Drugs Sales by Applications (2015-2020) Table Global Antiviral Drugs Sales Share by Applications (2015-2020) Table Global Antiviral Drugs Revenue ($) by Applications (2015-2020) Table Global Antiviral Drugs Revenue Share by Applications (2015-2020) Table Global Antiviral Drugs Market Forecast Sales by Applications (2020-2025) Table Global Antiviral Drugs Market Forecast Sales Share by Applications (2020-2025) Table Global Antiviral Drugs Market Forecast Revenue ($) by Applications (2020-2025) Table Global Antiviral Drugs Market Forecast Revenue Share by Applications (2020-2025) Figure Global Hepatitis Therapeutics Sales and Growth Rate (2015-2020) Figure Global Hepatitis Therapeutics Price (2015-2020) Figure Global HIV/AIDS Therapeutics Sales and Growth Rate (2015-2020) Figure Global HIV/AIDS Therapeutics Price (2015-2020) Figure Global Herpes Therapeutics Sales and Growth Rate (2015-2020) Figure Global Herpes Therapeutics Price (2015-2020) Figure Global Influenza Therapeutics Sales and Growth Rate (2015-2020) Figure Global Influenza Therapeutics Price (2015-2020) Figure Global Antiviral Drugs Market Revenue ($) and Growth Rate Forecast of Hepatitis Therapeutics (2020-2025) Figure Global Antiviral Drugs Sales and Growth Rate Forecast of Hepatitis Therapeutics (2020-2025) Figure Global Antiviral Drugs Market Revenue ($) and Growth Rate Forecast of HIV/AIDS Therapeutics (2020-2025) Figure Global Antiviral Drugs Sales and Growth Rate Forecast of HIV/AIDS Therapeutics (2020-2025) Figure Global Antiviral Drugs Market Revenue ($) and Growth Rate Forecast of Herpes Therapeutics (2020-2025) Figure Global Antiviral Drugs Sales and Growth Rate Forecast of Herpes Therapeutics (2020-2025) Figure Global Antiviral Drugs Market Revenue ($) and Growth Rate Forecast of Influenza Therapeutics (2020-2025) Figure Global Antiviral Drugs Sales and Growth Rate Forecast of Influenza Therapeutics (2020-2025) Figure Global Antiviral Drugs Sales and Growth Rate (2015-2020) Table Global Antiviral Drugs Sales by Regions (2015-2020) Table Global Antiviral Drugs Sales Market Share by Regions (2015-2020) Figure Global Antiviral Drugs Sales Market Share by Regions in 2019 Figure Global Antiviral Drugs Revenue and Growth Rate (2015-2020) Table Global Antiviral Drugs Revenue by Regions (2015-2020) Table Global Antiviral Drugs Revenue Market Share by Regions (2015-2020) Figure Global Antiviral Drugs Revenue Market Share by Regions in 2019 Table Global Antiviral Drugs Market Forecast Sales by Regions (2020-2025) Table Global Antiviral Drugs Market Forecast Sales Share by Regions (2020-2025) Table Global Antiviral Drugs Market Forecast Revenue ($) by Regions (2020-2025) Table Global Antiviral Drugs Market Forecast Revenue Share by Regions (2020-2025) Figure North America Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure North America Antiviral Drugs Market Revenue and Growth Rate (2015-2020) Figure North America Antiviral Drugs Market Forecast Sales (2020-2025) Figure North America Antiviral Drugs Market Forecast Revenue ($) (2020-2025) Figure North America COVID-19 Status Figure U.S. Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure Canada Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure Mexico Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure Europe Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure Europe Antiviral Drugs Market Revenue and Growth Rate (2015-2020) Figure Europe Antiviral Drugs Market Forecast Sales (2020-2025) Figure Europe Antiviral Drugs Market Forecast Revenue ($) (2020-2025) Figure Europe COVID-19 Status Figure Germany Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure United Kingdom Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure France Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure Italy Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure Spain Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure Russia Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure Asia-Pacific Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure Asia-Pacific Antiviral Drugs Market Revenue and Growth Rate (2015-2020) Figure Asia-Pacific Antiviral Drugs Market Forecast Sales (2020-2025) Figure Asia-Pacific Antiviral Drugs Market Forecast Revenue ($) (2020-2025) Figure Asia Pacific COVID-19 Status Figure China Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure Japan Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure South Korea Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure Australia Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure India Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure South America Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure South America Antiviral Drugs Market Revenue and Growth Rate (2015-2020) Figure South America Antiviral Drugs Market Forecast Sales (2020-2025) Figure South America Antiviral Drugs Market Forecast Revenue ($) (2020-2025) Figure Brazil Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure Argentina Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure Columbia Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure Middle East and Africa Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure Middle East and Africa Antiviral Drugs Market Revenue and Growth Rate (2015-2020) Figure Middle East and Africa Antiviral Drugs Market Forecast Sales (2020-2025) Figure Middle East and Africa Antiviral Drugs Market Forecast Revenue ($) (2020-2025) Figure UAE Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure Egypt Antiviral Drugs Market Sales and Growth Rate (2015-2020) Figure South Africa Antiviral Drugs Market Sales and Growth Rate (2015-2020)
Summary: Get latest Market Research Reports on Antiviral Drugs. Industry analysis & Market Report on Antiviral Drugs is a syndicated market report, published as Global Antiviral Drugs Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Antiviral Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
Last updated on 12 October, 2021